Safety of D(-)-lactic acid producing bacteria in the human infant

Journal of Pediatric Gastroenterology and Nutrition

Volumn 41, Issue 4, 2005, Pages 489-492

  Connolly, Eamonn ^a   Abrahamsson, Thomas ^b   Björkstén, Bengt ^c  

^a BioGaia AB ^*  (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID; PROBIOTIC AGENT; SD 2112; UNCLASSIFIED DRUG;

ALLERGY; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FECES ANALYSIS; HUMAN; IMMUNOMODULATION; INFANT; INFANT FEEDING; INFECTION; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LACTOBACILLUS REUTERI; LACTOBACILLUS REUTERI ATCC 55730; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SWEDEN;

COLONY COUNT, MICROBIAL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FECES; HUMANS; INFANT; INFANT, NEWBORN; INTESTINES; LACTIC ACID; LACTOBACILLUS REUTERI; PROBIOTICS; SAFETY;

BACTERIA (MICROORGANISMS); LACTOBACILLUS REUTERI;

EID: 26044460540     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000176179.81638.45     Document Type: Article

References (31)

1. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-20.
2. Mitsuoka T. The human gastrointestinal tract. In: Wood BJ, ed. The Lactic Acid Bacteria, Vol. 1. New York: Elsevier, 1992:69-114.
3. Björkstén B, Sepp E, Julge K, et al. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001;108:516-20.
4. Mikelsaar M, Annuk A, Shchepetova J, et al. Intestinal lactobacilli of Estonian and Swedish children. Microb Ecol Health Dis 2002; 14:75-80.
5. Kalliomäki M, Salminen S, Arvilommi H, et al. Probiotics in the primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076-79.
6. Lapierre L, Germond JE, Ott A, et al. D-lactate dehydrogenase gene (1dhD) inactivation and resulting metabolic effects in the Lactobacillus johnsonii strains La1 and N312. Appl Environ Microbiol 1999;65:4002-7.
7. Uribarri J, Oh MS, Carroll HJ. D-lactic acidosis. A review of clinical presentation, biochemical features, and pathological mechanisms. Medicine (Baltimore) 1998;77:73-82.
8. Hove H. Lactate and short chain fatty acid production in the human colon: implications for D-lactic acidosis, short bowel syndrome, antibiotic-associated diarrhoea, colon cancer and inflammatory bowel disease. Dan Med Bull 1998;45:15-33.
9. Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005;115:5-9.
10. Shornikova A, Casas IA, Mykkanen H, et al. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J 1997;6:1103-7.
11. Shornikova A, Isolauri E, Casas IA, et al. Lactobacillus reuteri as a therapeutic agent in acute diarrhoea in young children. J Pediatr Gastroenterol Nutr 1997;24:399-404.
12. Wolf BW, Garleb KA, Ataya DG, et al. Safety and tolerance of Lactobacillus reuteri in healthy adult subjects. Microb Ecol Health Dis 1995;8:41-50.
13. Wolf BW, Wheeler KB, Ataya DG, et al. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency. Virus Food Chem Toxicol 1998;36: 1085-94.
14. Weizman Z, Alsheikh A. Safety of infant formula supplemented with probiotics in early infancy. Clin Nutr 2003;22(Suppl 1):S69-70.
15. Gawehn K. D-(-)-Lactate In: Bermeyer HU, ed. Methods of Enzymatic Analysis. 3rd ed. Weinheim: Verlag Chemie, 1984: 588-92.
16. Valeur N, Engel P, Carbajal N, et al. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 2004;70: 1176-81.
17. Anderson YS, Curtis NJ, Hobbs JA, et al. High serum D-lactate in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1997;12:981-3.
18. Brandt RB, Siegel SA, Waters MG, et al. Spectrophoomteric analysis for D-(-)-lactate in plasma. Anal Biochem 1980;102:39-46.
19. Vella A, Farrugia G. D-lactic acidosis: pathologic consequence of saprophytism. Mayo Clin Proc 1998;73:451-6.
20. Jacobs HM, Christian JR. Observations on full-term newborn infants receiving an acidified milk formula. Lancet 1957;77:157-9.
21. Droese W, Stolley H. Funktionelle Prüfungen von Säugling- snahrungen; dargestellt an der säuremilchernährung junger säuglinge. Dtsch Med J 1962;13:107.
22. Droese W, Stolley H. Die Wirkung von milchsäure (D/L), citronsäure undprotienauf ddie organischen säuren im harn von gesunden säugligen im 1. lebensvierteljahr. In: Symp über die Ernährung der Frühgeborenen, Bad Schachen, Mai 1964. Basel/New York: Karger, 1965;63-72.
23. Food and Agricultural Organisation/World Health Organisation. Toxicological evaluation of certain food additives with a review of general principles and of specifications. In: WHO Technical Report Series. Geneva: FAO and WHO, 1974:1-40.
24. WHO food additives series no.5, 1974. Available at: http://www. inchem.org/documents/jecfa/jecmono/v05je86.htm. Accessed August 5, 2004.
25. Martin R, Langa S, Reviriego C, et al. The commensal microflora of human milk: new perspectives for food bacteriotherapy and probiotics. Trends Food Sci Technol 2004;15:121-7.
26. Reuter G. The lactobacillus and bifidobacterium microflora of the human intestine: composition and succession. Curr Issues Intest Microbiol 2001;2:43-5.
27. Weizman Z, Asli G, Alsheikh A. Infant formula supplemented with probiotics reduces gastrointestinal infections rate in day care infants Clin Nutr 2003;22(Suppl 1):S69.
28. Shornikova A, Isolauri E, Casas IA, et al. Lactobacillus reuteri as a therapeutic agent in acute diarrhoea in young children. J Pediatr Gastroenterol Nutr 1997;24:399-404.
29. Shornikova A, Casas IA, Mykkanen H, et al. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J 1997;6:1103-7.
30. Mack DR. D(-)-lactic acid producing probiotics, D(-)-lactic acidosis and infants. Can J Gastroenterol 2004;18:671-5.
31. Vanderhof JA, Young RJ, Murray N, et al. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr 1998;27:155-60.